Supplementary Table S1 from An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i>-Mutant Intrahepatic Cholangiocarcinoma
Mao Zhang(Fudan University), Qiang Gao(Northeastern University), Wei Wu(Stanford University), Sirui Zhang(Brigham and Women's Hospital), Jiaomeng Pan(Fudan University), Fen Liu(Chinese Academy of Sciences), Chen Sang(Fudan University), Yuyan Zheng(Ruijin Hospital), Yingying Huang(Shanghai Institute of Nutrition and Health), Yingcheng Wu(Stanford University), Shuyi Ji(Fudan University), Jian Lin(Fudan University), Guohe Song(Fudan University), Daming Gao(Westlake University), Youpei Lin(Zhongshan Hospital), Jia Fan(Nanjing Tech University), Jian Zhou(Ministry of Education of the People's Republic of China), Zefeng Wang(Southern University of Science and Technology), Jianke Ren(Shanghai Institute of Nutrition and Health), Mengcheng Wang(University of Nebraska Medical Center), Xia Shen(Taiyuan University of Technology), Liangqing Dong(Fudan University)
Cited by 0
Related Papers
FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
|Cell Research|2014|1.2k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
|Nature|2011|866
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828